Annual EBITDA:
-$120.46M+$209.88M(+63.53%)Summary
- As of today, PTCT annual EBITDA is -$120.46 million, with the most recent change of +$209.88 million (+63.53%) on December 31, 2024.
- During the last 3 years, PTCT annual EBITDA has risen by +$247.72 million (+67.28%).
- PTCT annual EBITDA is now -460.09% below its all-time high of $33.45 million, reached on December 31, 2011.
Performance
PTCT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$33.11M-$1.00B(-103.41%)Summary
- As of today, PTCT quarterly EBITDA is -$33.11 million, with the most recent change of -$1.00 billion (-103.41%) on June 30, 2025.
- Over the past year, PTCT quarterly EBITDA has increased by +$2.11 million (+6.00%).
- PTCT quarterly EBITDA is now -103.41% below its all-time high of $971.14 million, reached on March 31, 2025.
Performance
PTCT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$841.26M+$2.11M(+0.25%)Summary
- As of today, PTCT TTM EBITDA is $841.26 million, with the most recent change of +$2.11 million (+0.25%) on June 30, 2025.
- Over the past year, PTCT TTM EBITDA has increased by +$973.40 million (+736.65%).
- PTCT TTM EBITDA is now at all-time high.
Performance
PTCT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PTCT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +63.5% | +6.0% | +736.6% |
| 3Y3 Years | +67.3% | +66.0% | +332.4% |
| 5Y5 Years | +38.3% | +80.0% | +354.6% |
PTCT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +67.3% | -103.4% | +78.9% | at high | +298.1% |
| 5Y | 5-Year | at high | +67.3% | -103.4% | +78.9% | at high | +298.1% |
| All-Time | All-Time | -460.1% | +67.3% | -103.4% | +80.0% | at high | +298.1% |
PTCT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$33.11M(-103.4%) | $841.26M(+0.3%) |
| Mar 2025 | - | $971.14M(+2171.8%) | $839.14M(+796.6%) |
| Dec 2024 | -$120.46M(+63.5%) | -$46.88M(+6.1%) | -$120.46M(-14.0%) |
| Sep 2024 | - | -$49.90M(-41.6%) | -$105.66M(+20.0%) |
| Jun 2024 | - | -$35.23M(-405.4%) | -$132.14M(+48.0%) |
| Mar 2024 | - | $11.53M(+136.0%) | -$253.97M(+23.1%) |
| Dec 2023 | -$330.34M(+10.2%) | -$32.07M(+58.0%) | -$330.34M(+22.2%) |
| Sep 2023 | - | -$76.38M(+51.4%) | -$424.60M(-1.1%) |
| Jun 2023 | - | -$157.06M(-142.2%) | -$420.07M(-16.5%) |
| Mar 2023 | - | -$64.83M(+48.7%) | -$360.55M(+2.0%) |
| Dec 2022 | -$367.78M(+0.1%) | -$126.33M(-75.8%) | -$367.78M(-8.6%) |
| Sep 2022 | - | -$71.85M(+26.3%) | -$338.75M(+6.4%) |
| Jun 2022 | - | -$97.54M(-35.4%) | -$362.00M(-5.0%) |
| Mar 2022 | - | -$72.06M(+25.9%) | -$344.80M(+6.4%) |
| Dec 2021 | -$368.18M(-21.5%) | -$97.30M(-2.3%) | -$368.19M(-24.4%) |
| Sep 2021 | - | -$95.11M(-18.4%) | -$295.92M(-37.3%) |
| Jun 2021 | - | -$80.34M(+15.8%) | -$215.53M(+28.4%) |
| Mar 2021 | - | -$95.44M(-281.4%) | -$300.95M(+0.7%) |
| Dec 2020 | -$303.09M(-55.2%) | -$25.03M(-70.0%) | -$303.09M(+8.3%) |
| Sep 2020 | - | -$14.72M(+91.1%) | -$330.36M(+9.5%) |
| Jun 2020 | - | -$165.75M(-69.9%) | -$365.17M(-58.3%) |
| Mar 2020 | - | -$97.59M(-86.6%) | -$230.65M(-18.1%) |
| Dec 2019 | -$195.25M(-118.2%) | -$52.29M(-5.6%) | -$195.25M(-7.8%) |
| Sep 2019 | - | -$49.53M(-58.6%) | -$181.20M(-4.8%) |
| Jun 2019 | - | -$31.24M(+49.8%) | -$172.82M(-22.6%) |
| Mar 2019 | - | -$62.19M(-62.6%) | -$140.94M(-57.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$89.47M(-92.0%) | -$38.24M(+7.1%) | -$89.47M(-124.6%) |
| Sep 2018 | - | -$41.16M(-6461.2%) | -$39.84M(-106.6%) |
| Jun 2018 | - | $647.00K(+106.0%) | -$19.28M(+39.0%) |
| Mar 2018 | - | -$10.72M(-194.1%) | -$31.59M(+32.2%) |
| Dec 2017 | -$46.61M(+63.8%) | $11.39M(+155.3%) | -$46.61M(+43.3%) |
| Sep 2017 | - | -$20.60M(-76.6%) | -$82.18M(+11.5%) |
| Jun 2017 | - | -$11.66M(+54.7%) | -$92.83M(+20.6%) |
| Mar 2017 | - | -$25.74M(-6.5%) | -$116.92M(+9.2%) |
| Dec 2016 | -$128.77M(+21.6%) | -$24.18M(+22.6%) | -$128.77M(+15.3%) |
| Sep 2016 | - | -$31.25M(+12.6%) | -$151.99M(+6.3%) |
| Jun 2016 | - | -$35.74M(+4.9%) | -$162.21M(+1.3%) |
| Mar 2016 | - | -$37.59M(+20.7%) | -$164.41M(-0.1%) |
| Dec 2015 | -$164.25M(-69.0%) | -$47.40M(-14.3%) | -$164.25M(-10.6%) |
| Sep 2015 | - | -$41.47M(-9.3%) | -$148.54M(-10.7%) |
| Jun 2015 | - | -$37.94M(-1.3%) | -$134.12M(-10.9%) |
| Mar 2015 | - | -$37.44M(-18.1%) | -$120.99M(-24.5%) |
| Dec 2014 | -$97.18M(-126.0%) | -$31.69M(-17.1%) | -$97.18M(-17.1%) |
| Sep 2014 | - | -$27.06M(-9.1%) | -$83.00M(-39.2%) |
| Jun 2014 | - | -$24.81M(-82.1%) | -$59.63M(-22.5%) |
| Mar 2014 | - | -$13.62M(+22.2%) | -$48.67M(-13.2%) |
| Dec 2013 | -$43.00M(-78.4%) | -$17.51M(-374.9%) | -$43.00M(-39.3%) |
| Sep 2013 | - | -$3.69M(+73.4%) | -$30.87M(-13.6%) |
| Jun 2013 | - | -$13.86M(-74.3%) | -$27.19M(-103.9%) |
| Mar 2013 | - | -$7.95M(-47.8%) | -$13.33M(-22.8%) |
| Dec 2012 | -$24.10M(-172.1%) | -$5.38M(+1.7%) | -$10.85M(-98.3%) |
| Mar 2012 | - | -$5.47M | -$5.47M |
| Dec 2011 | $33.45M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual EBITDA year-on-year change?
- What is PTC Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is PTC Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM EBITDA year-on-year change?
What is PTC Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of PTCT is -$120.46M
What is the all-time high annual EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual EBITDA is $33.45M
What is PTC Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, PTCT annual EBITDA has changed by +$209.88M (+63.53%)
What is PTC Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of PTCT is -$33.11M
What is the all-time high quarterly EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly EBITDA is $971.14M
What is PTC Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, PTCT quarterly EBITDA has changed by +$2.11M (+6.00%)
What is PTC Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of PTCT is $841.26M
What is the all-time high TTM EBITDA for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM EBITDA is $841.26M
What is PTC Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, PTCT TTM EBITDA has changed by +$973.40M (+736.65%)